[SPECT findings in the hemiparkinson syndrome using 99mTc-HMPAO].
The symptoms of Parkinson's disease often begin on one side of the body and continue to do so as the disease progresses. First SPECT results in 4 patients with hemiparkinsonism using 99mTc-HMPAO as perfusion marker are reported. Three patients exhibited reduced tracer uptake in the contralateral basal ganglia. One patient who was under therapy for 1 year, showed a different perfusion pattern with reduced uptake in both basal ganglia. These results might indicate reduced perfusion secondary to reduced striatal neuronal activity.
Neumann
C
C
Abteilungen für Nuklearmedizin und Neurologie, Goethe-Universität, Frankfurt, BRD.
Baas
H
H
Hefner
R
R
Hör
G
G
D001479:Basal Ganglia / Q000000981:diagnostic imaging; D005260:Female; D007839:Functional Laterality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D010091:Oximes; D010300:Parkinson Disease / Q000000981:diagnostic imaging*; D010477:Perfusion; D013667:Technetium; D019690:Technetium Tc 99m Exametazime; D014055:Tomography, Emission-Computed
D009942:Organometallic Compounds; D010091:Oximes; D019690:Technetium Tc 99m Exametazime; D013667:Technetium
SPECT-Befunde bei Hemiparkinson-Syndrom mit 99mTc-HMPAO.